Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03528668 · ClinicalTrials.gov registry record
Patient Receptiveness to Using Virtual Reality
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 89
- Enrollment target
NCT03528668: Completed study, sponsored by Massachusetts General Hospital.
NCT03528668 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 89 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03528668 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 89 participants
- Enrollment target
Study Summary
This study will evaluate the acceptability, use, and general effect that exposure to virtual reality has on hospitalized patients reporting at least one discomfort including recent or current moderate-severe pain.
Interventions
- DEVICE Virtual Reality Exposure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2018-04-16 |
| Est. Completion | 2018-10-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03528668
The ClinicalTrials.gov registry entry for NCT03528668 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Virtual Reality Exposure is the first listed.
NCT03528668 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03528668 about?
NCT03528668 is a clinical study titled "Patient Receptiveness to Using Virtual Reality". This study will evaluate the acceptability, use, and general effect that exposure to virtual reality has on hospitalized patients reporting at least one discomfort including recent or current moderate-severe pain.
What is the current status of trial NCT03528668?
This trial is currently completed. The enrollment target is 89 participants. The study started on 2018-04-16. Estimated completion is 2018-10-12.
What interventions are being tested in trial NCT03528668?
The interventions under investigation include: Virtual Reality Exposure (DEVICE).
Who is sponsoring clinical trial NCT03528668?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.